{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.466","value":"-0.12"},{"groupId":"OG001","spread":"0.530","value":"-0.60"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"222"},{"groupId":"OG001","value":"233"}],"units":"Participants"}],"description":"The Health Assessment Questionnaire-Disability Index (HAQ-DI) is a 20-question instrument that assesses the degree of difficulty a person has in accomplishing tasks in 8 functional areas (dressing, arising, eating, walking, hygiene, reaching, gripping and activities of daily living). Responses in each functional area are scored from 0 to 3 (0=no difficulty and 3=inability to perform a task in that area). Overall score was computed as the sum of domain scores and divided by the number of domains answered. Total possible score range 0-3 where 0 = least difficulty and 3 = extreme difficulty.","dispersionType":"Standard Deviation","groups":[{"description":"Participants received intravenous infusions of placebo at Weeks 0, 4, 12 and 20.","id":"OG000","title":"Placebo"},{"description":"Participants were randomized to receive intravenous infusions of golimumab 2 mg/kg at Weeks 0, 4 and thereafter every 8 weeks up to Week 52. At Week 24, participants received a placebo infusion to maintain the blind.","id":"OG001","title":"Golimumab"}],"paramType":"MEAN","populationDescription":"The full analysis set (FAS) included all participants who were randomized. Here \"N\" (number of participants analyzed) signifies the number of participants who were evaluable for this outcome measure.","reportingStatus":"POSTED","timeFrame":"Baseline and Week 14","title":"Change From Baseline in Health Assessment Questionnaire-Disability Index (HAQ-DI) Score at Week 14","type":"SECONDARY","unitOfMeasure":"units on a scale"}